LENZ Therapeutics, Inc. (LENZ) Current Leases (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Current Leases for 2 consecutive years, with $3.4 million as the latest value for Q3 2023.
- On a quarterly basis, Current Leases fell 26.09% to $3.4 million in Q3 2023 year-over-year; TTM through Sep 2023 was $3.4 million, a 26.09% decrease, with the full-year FY2022 number at $4.0 million, changed N/A from a year prior.
- Current Leases was $3.4 million for Q3 2023 at LENZ Therapeutics, up from $2.9 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.6 million in Q1 2022 to a low of $2.9 million in Q2 2023.